Mrs Megan Roth Wink, | |
5301 South Congress Avenue, Jfk Medical Center, Atlantis, FL 33462 | |
(561) 965-7300 | |
Not Available |
Full Name | Mrs Megan Roth Wink |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 8 Years |
Location | 5301 South Congress Avenue, Atlantis, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952840993 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 9265466 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Jfk Medical Center | Atlantis, FL | Hospital |
Bethesda Hospital Inc | Boynton beach, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Sheridan Healthcorp Inc | 3173429693 | 866 |
Anesthesia Physician Solutions Of South Florida, Llc | 4688805286 | 220 |
News Archive
An international team of researchers, including scientists from the University of Dundee have announced that cyanobacteria (blue-green algae) found throughout the world may produce a toxin linked to certain types of neurological disease.
GNAX Health, Acuo Technologies and Client Outlook, announced today the formation of a new strategic alliance to provide an integrated and simplified solution for medical image access, exchange and management.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.
Stronger alcohol policies, including those targeting both excessive drinking and driving while impaired by alcohol, reduce the likelihood of alcohol-related motor vehicle crash deaths, according to a new study from Boston Medical Center and Boston University.
› Verified 1 days ago
Entity Name | Sheridan Healthcorp Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629781711 PECOS PAC ID: 3173429693 Enrollment ID: O20031208000355 |
News Archive
An international team of researchers, including scientists from the University of Dundee have announced that cyanobacteria (blue-green algae) found throughout the world may produce a toxin linked to certain types of neurological disease.
GNAX Health, Acuo Technologies and Client Outlook, announced today the formation of a new strategic alliance to provide an integrated and simplified solution for medical image access, exchange and management.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.
Stronger alcohol policies, including those targeting both excessive drinking and driving while impaired by alcohol, reduce the likelihood of alcohol-related motor vehicle crash deaths, according to a new study from Boston Medical Center and Boston University.
› Verified 1 days ago
Entity Name | Anesthesiologists Of Greater Orlando Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457300998 PECOS PAC ID: 7416928536 Enrollment ID: O20040803000929 |
News Archive
An international team of researchers, including scientists from the University of Dundee have announced that cyanobacteria (blue-green algae) found throughout the world may produce a toxin linked to certain types of neurological disease.
GNAX Health, Acuo Technologies and Client Outlook, announced today the formation of a new strategic alliance to provide an integrated and simplified solution for medical image access, exchange and management.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.
Stronger alcohol policies, including those targeting both excessive drinking and driving while impaired by alcohol, reduce the likelihood of alcohol-related motor vehicle crash deaths, according to a new study from Boston Medical Center and Boston University.
› Verified 1 days ago
Entity Name | St Lucie Anesthesia Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700044252 PECOS PAC ID: 4284792706 Enrollment ID: O20081027000765 |
News Archive
An international team of researchers, including scientists from the University of Dundee have announced that cyanobacteria (blue-green algae) found throughout the world may produce a toxin linked to certain types of neurological disease.
GNAX Health, Acuo Technologies and Client Outlook, announced today the formation of a new strategic alliance to provide an integrated and simplified solution for medical image access, exchange and management.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.
Stronger alcohol policies, including those targeting both excessive drinking and driving while impaired by alcohol, reduce the likelihood of alcohol-related motor vehicle crash deaths, according to a new study from Boston Medical Center and Boston University.
› Verified 1 days ago
Entity Name | Anesthesia Physician Solutions Of South Florida, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104248699 PECOS PAC ID: 4688805286 Enrollment ID: O20140325000665 |
News Archive
An international team of researchers, including scientists from the University of Dundee have announced that cyanobacteria (blue-green algae) found throughout the world may produce a toxin linked to certain types of neurological disease.
GNAX Health, Acuo Technologies and Client Outlook, announced today the formation of a new strategic alliance to provide an integrated and simplified solution for medical image access, exchange and management.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.
Stronger alcohol policies, including those targeting both excessive drinking and driving while impaired by alcohol, reduce the likelihood of alcohol-related motor vehicle crash deaths, according to a new study from Boston Medical Center and Boston University.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Megan Roth Wink, 5571 N Winston Park Blvd, Apt. 102, Coconut Creek, FL 33073-5044 Ph: (561) 379-7037 | Mrs Megan Roth Wink, 5301 South Congress Avenue, Jfk Medical Center, Atlantis, FL 33462 Ph: (561) 965-7300 |
News Archive
An international team of researchers, including scientists from the University of Dundee have announced that cyanobacteria (blue-green algae) found throughout the world may produce a toxin linked to certain types of neurological disease.
GNAX Health, Acuo Technologies and Client Outlook, announced today the formation of a new strategic alliance to provide an integrated and simplified solution for medical image access, exchange and management.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.
Stronger alcohol policies, including those targeting both excessive drinking and driving while impaired by alcohol, reduce the likelihood of alcohol-related motor vehicle crash deaths, according to a new study from Boston Medical Center and Boston University.
› Verified 1 days ago
Joseph J Catalina, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5301 S Congress Ave, Atlantis, FL 33462 Phone: 561-965-7300 | |
Heather N Stokes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5301 S Congress Ave, Atlantis, FL 33462 Phone: 561-965-7300 | |
Danielle Witkowski, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5301 S Congress Ave, Atlantis, FL 33462 Phone: 561-965-7300 Fax: 954-514-3979 | |
Lidiya Pastukh, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5301 S Congress Ave, Atlantis, FL 33462 Phone: 561-965-7300 | |
Eileen O'hara, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 5301 S Congress Ave, Atlantis, FL 33462 Phone: 561-965-7300 | |
Jennifer Vanetti Quinn, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5301 S Congress Ave, Jfk Medical Center, Atlantis, FL 33462 Phone: 561-965-7300 | |
Priscilla Dias, RN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5301 S. Congress Ave, Jfk Medical Center,, Atlantis, FL 33462 Phone: 561-548-9275 |